IMPACT [gngm]
Dyslipidaemia [dsyn]
end stage heart disease [dsyn]
Renal disease [dsyn]
Morbidity [qnco]
Mortality [qnco]
Patients [podg]
Renal Failure [dsyn]
Heart disease, premature [fndg]
atherosclerotic [ftcn]
coronary [bpoc]
Drive [menp]
Multiple [qnco]
risk factors [qnco]
Including [ftcn]
Dyslipidaemia [dsyn]
Oxidative Stress [comd]
treatment [ftcn]
Dyslipidaemia [dsyn]
CARDIOVASCULAR [bdsy]
Dialysis [npop]
Patients [podg]
Atherogenesis [patf]
Lipid [lipd]
Abnormalities [cgab]
Cholesterol, LDL [bacs, strd]
Patients [podg]
Haemodialysis [topp]
Normal [qlco]
Near [fndg]
Normal [qlco]
Increased [qnco]
oxidized LDL [aapp, bacs]
Cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Decreased HDL cholesterol [fndg]
triglyceride VLDL [aapp, bacs, lipd]
Rich [qlco]
Note [clna]
Patients [podg]
Receive [qlco]
Peritoneal Dialysis [topp]
Atherogenesis [patf]
Lipid [lipd]
Profile [lbpr]
Increased LDL cholesterol [fndg]
Apolipoprotein B [aapp, bacs]
oxidized LDL [aapp, bacs]
Cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
Lp(a) [aapp, bacs]
Decreased HDL cholesterol [fndg]
LDL particle [celc]
Peritoneal Dialysis [topp]
Patients [podg]
Small [qnco]
Dense [qlco]
Information [idcn]
Goals [inpr]
Efficacy [qlco]
Safety [hcpp]
Dyslipidaemia [dsyn]
treatment [ftcn]
Dialysis [npop]
Patients [podg]
GIVEN [cnce]
Strong [qlco]
Risk Reduction [inbe]
Benefits [qnco]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Consensus [socb]
Dialysis [npop]
Patients [podg]
treated [topp]
Dyslipidaemia [dsyn]
Cholesterol, LDL [bacs, strd]
Goal [inpr]
mg dl [qnco]
Physicians [prog]
Patients [podg]
Reluctant [menp]
ADD [mobd]
Medications [phsu]
Concerns [idcn]
Polypharmacy [fndg]
Decreased [qnco]
Compliance [qnco]
Increased [qnco]
Cost [qnco]
Agent [chvf]
sevelamer [orch, phsu]
Multiple [qnco]
Functions [ftcn]
Including [ftcn]
Phosphate [inch, phsu]
Lipid [lipd]
lowering [spco]
Decreased [qnco]
Cholesterol, LDL [bacs, strd]
Total Cholesterol [lbpr]
Anti-inflammatory effect [qlco]
Decreased Sensitivity [fndg]
C-reactive protein [aapp, imft]
considered [idcn]
Patients [podg]
Benefit [qnco]
treatment [ftcn]
